OBJECTIVE: This study aimed to determine whether small fiber polyneuropathy (SFPN) diagnosis differs between Hunner lesion interstitial cystitis/bladder pain syndrome (HL IC/BPS) and non-Hunner lesion IC/BPS (NHL IC/BPS). METHODS: This was a pilot study of 20 women with IC/BPS. Results from baseline questionnaires, such as Genitourinary Pain Index, Interstitial Cystitis Symptom Index/Interstitial Cystitis Problem Index (ICSI/ICPI), Patient Health Questionnaire-2, were collected.Two punch biopsies were performed on each patient: distal leg and thigh. The samples were evaluated for intraepidermal nerve fiber density. One intraepidermal nerve fiber density less than the fifth percentile, regardless of site, indicated a positive SPFN diagnosis. RESULTS: Twenty patients were enrolled; 10 HL IC/BPS and 10 NHL IC/BPS. The HL IC/BPS group was found to be significantly older than the NHL IC/BPS group (63 vs 48 years, P = 0.007). No significant differences were found in employment or relationship statuses, or in levels of education or comorbidities between the 2 groups.Sixty percent (6/10) of patients had SFPN in the NHL IC/BPS group compared with 40% (4/10) in the HL IC/BPS group. No significant differences were seen in SFPN positivity (P = 0.3) or Genitourinary Pain Index, Patient Health Questionnaire-2, or Interstitial Cystitis Symptom Index/Interstitial Cystitis Problem Index scores between the NHL and HL IC/BPS groups. CONCLUSIONS: Similar to previously published studies, 60% of NHL IC/BPS patients in this cohort were positive for SFPN compared with only 40% of the HL IC/BPS patients. Larger studies may be needed to realize the full impact of SFPN in IC/BPS.
References
Ahangari A. Prevalence of chronic pelvic pain among women: an updated review. Pain Physician 2014;17(2):E141–E147.
Riegel B, Bruenahl CA, Ahyai S, et al. Assessing psychological factors, social aspects and psychiatric co-morbidity associated with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) in men—a systematic review. J Psychosom Res 2014;77(5):333–350.
Oaklander AL, Herzog ZD, Downs HM, et al. Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia. Pain 2013;154(11):2310–2316.
Lauria G, Hsieh ST, Johansson O, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2010;17(7):903–912 e944-909.
Chen A, De E, Argoff C. Small fiber polyneuropathy is prevalent in patients experiencing complex chronic pelvic pain. Pain Med 2018;20(3):521–527.
Nickel JC, Tripp DA, Pontari M, et al. Interstitial cystitis/painful bladder syndrome and associated medical conditions with an emphasis on irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome. J Urol 2010;184(4):1358–1363.
Doggweiler R, Whitmore KE, Meijlink JM, et al. A standard for terminology in chronic pelvic pain syndromes: a report from the Chronic Pelvic Pain Working Group of the International Continence Society. NeurourolUrodyn 2017;36(4):984–1008.
Koziol JA, Adams HP, Frutos A. Discrimination between the ulcerous and the nonulcerous forms of interstitial cystitis by noninvasive findings. J Urol 1996;155(1):87–90.
Grégoire M, Liandier F, Naud A, et al. Does the potassium stimulation test predict cystometric, cystoscopic outcome in interstitial cystitis? J Urol 2002;168(2):556–557.
Simon LJ, Landis JR, Erickson DR, et al. The Interstitial Cystitis Data Base Study: concepts and preliminary baseline descriptive statistics. Urology 1997;49(5A Suppl):64–75.
Braunstein R, Shapiro E, Kaye J, et al. The role of cystoscopy in the diagnosis of Hunner’s ulcer disease. J Urol 2008;180(4):1383–1386.
Peeker R, Fall M. Toward a precise definition of interstitial cystitis: further evidence of differences in classic and nonulcer disease. J Urol 2002;167(6):2470–2472.
Peters KM, Killinger KA, Mounayer MH, et al. Are ulcerative and nonulcerative interstitial cystitis/painful bladder syndrome 2 distinct diseases? A study of coexisting conditions. Urology 2011;78(2):301–308.
Warren JW, Wesselmann U, Morozov V, et al. Numbers and types of nonbladder syndromes as risk factors for interstitial cystitis/painful bladder syndrome. Urology 2011;77(2):313–319.
Warren JW, Howard FM, Cross RK, et al. Antecedent nonbladder syndromes in case-control study of interstitial cystitis/painful bladder syndrome. Urology 2009;73(1):52–57.
Buffington CA. Comorbidity of interstitial cystitis with other unexplained clinical conditions. J Urol 2004;172(4 Pt 1):1242–1248.
Tirlapur SA, Kuhrt K, Chaliha C, et al. The ’evil twin syndrome’ in chronic pelvic pain: a systematic review of prevalence studies of bladder pain syndrome and endometriosis. Int J Surg 2013;11(3):233–237.
Vitale SG, La Rosa VL, Rapisarda AMC, et al. Impact of endometriosis on quality of life and psychological well-being. J Psychosom Obstet Gynaecol 2017;38(4):317–319.
Bogart LM, Berry SH, Clemens JQ. Symptoms of interstitial cystitis, painful bladder syndrome and similar diseases in women: a systematic review. J Urol 2007;177(2):450–456.
Lai HH, Gardner V, Ness TJ, et al. Segmental hyperalgesia to mechanical stimulus in interstitial cystitis/bladder pain syndrome: evidence of central sensitization. J Urol 2014;191(5):1294–1299.
Clemens JQ, Calhoun EA, Litwin MS, et al. Validation of a modified National Institutes of Health chronic prostatitis symptom index to assess genitourinary pain in both men and women. Urology 2009;74(5):983–987, quiz 987.e981–983.
O’Leary MP, Sant GR, Fowler FJ Jr., et al. The interstitial cystitis symptom index and problem index. Urology 1997;49(5A Suppl):58–63.
Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994;23(2):129–138.
Cleeland CS. The Brief Pain Inventory User Guide. Houston, TX: MD Anderson Cancer Center; 2009.
Mangus LM, Rao DB, Ebenezer GJ. Intraepidermal nerve Fiber analysis in human patients and animal models of peripheral neuropathy: a comparative review. Toxicol Pathol 2019;192623319855969.
Poquet N, Lin C. The brief pain inventory (BPI). J Physiother 2016;62(1):52.
Lindell L, Bergman S, Petersson IF, et al. Prevalence of fibromyalgia and chronic widespread pain. Scand J Prim Health Care 2000;18(3):149–153.
White KP, Speechley M, Harth M, et al. The London Fibromyalgia Epidemiology Study: direct health care costs of fibromyalgia syndrome in London, Canada. J Rheumatol 1999;26(4):885–889.
Caro XJ, Winter EF. Evidence of abnormal epidermal nerve fiber density in fibromyalgia: clinical and immunologic implications. Arthritis Rheumatol 2014;66(7):1945–1954.
Üçeyler N, Zeller D, Kahn AK, et al. Small fibre pathology in patients with fibromyalgia syndrome. Brain 2013;136(Pt 6):1857–1867.
Oaklander AL, Downs H, Herzog ZD, et al. Small-fiber polyneuropathy (SFPN), a common underlying diagnosis in syndromes involving unexplained chronic pain an multi-system symptoms. Molec Pain 2014;10(Suppl 1):O12.
Hovaguimian A, Gibbons CH. Diagnosis and treatment of pain in small-fiber neuropathy. Curr Pain Headache Rep 2011;15(3):193–200.
Hutson P, Backonja M, Knurr H. Intravenous lidocaine for neuropathic pain: a retrospective analysis of tolerability and efficacy. Pain Med 2015;16(3):531–536.
Caro XJ, Winter EF, Dumas AJ. A subset of fibromyalgia patients have findings suggestive of chronic inflammatory demyelinating polyneuropathy and appear to respond to IVIg. Rheumatology (Oxford) 2008;47(2):208–211.
Fall MJS, Aldenborg F. Chronic interstitial cystitis: a heterogeneous syndrome. J Urol 1987;137:35–38.
